Flufenamic acid is a nonsteroidal anti-inflammatory drug (NSAID). Inhibits calcium-activated chloride channels (CaCCs). Also increases currents through TRPC6 channels and inhibits currents through TRPC3 and TRPC7 channels.
More Information Supplier PageFlufenamic acid is a nonsteroidal anti-inflammatory drug (NSAID). Inhibits calcium-activated chloride channels (CaCCs). Also increases currents through TRPC6 channels and inhibits currents through TRPC3 and TRPC7 channels.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageTrelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
More Information Supplier PageTrelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
More Information Supplier PageTrelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
More Information Supplier Page
